StoneX Group’s ProPhase Labs PRPH Stock Holding History

StoneX Group’s Portfolio PRPH Stock Details PRPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,000	Closed	-$8.95K	–	1179
2025 Q4	$8.95K	Buy	+20,000	New	+$56.3K	﹤0.01%	1008

Other funds holding PRPH

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

StoneX Group's PRPH Position: Q1 2026 in Review

StoneX Group sold out of ProPhase Labs (PRPH) in Q1 2026, closing a stake of 20,000 shares — an estimated $8.95K sold.

StoneX Group first reported a position in PRPH in Q4 2025 and held it in 1 quarter. The position peaked at $8.95K in Q4 2025. 2 funds tracked by Wall St. Rank hold PRPH as of Q1 2026.

StoneX Group reported no remaining ProPhase Labs position as of Q1 2026 after selling out during the quarter.
StoneX Group sold 20,000 ProPhase Labs shares in Q1 2026, an estimated $8.95K.
StoneX Group first reported a position in ProPhase Labs in Q4 2025 and held it in 1 quarter.
StoneX Group's ProPhase Labs position peaked at $8.95K in Q4 2025.
2 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.